Goldstein Barry J相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Clinical endpoints and adaptive clinical trials in precirrhotic nonalcoholic steatohepatitis: Facilitating development approaches for an emerging epidemic

临床终点和适应性临床试验在肝硬化前期非酒精性脂肪性肝炎中的应用：促进应对新兴流行病的开发方法

期刊:Hepatology Communications

影响因子:4.6

doi:10.1002/hep4.1079

Filozof, Claudia; Chow, Shein-Chung; Dimick-Santos, Lara; Chen, Yeh-Fong; Williams, Richard N; Goldstein, Barry J; Sanyal, Arun

发表日期：2017

文献求助收藏

Comparison of treatment with sitagliptin or sulfonylurea in patients with type 2 diabetes mellitus and mild renal impairment: a post hoc analysis of clinical trials

比较西格列汀或磺脲类药物治疗2型糖尿病合并轻度肾功能损害患者的疗效：一项临床试验的事后分析

期刊:Diabetes Therapy

影响因子:2.6

doi:10.1007/s13300-015-0098-y

Ommen, Elizabeth S; Xu, Lei; O'Neill, Edward A; Goldstein, Barry J; Kaufman, Keith D; Engel, Samuel S

发表日期：2015

文献求助收藏

Erratum to: Comparison of Treatment with Sitagliptin or Sulfonylurea in Patients with Type 2 Diabetes Mellitus and Mild Renal Impairment: A Post Hoc Analysis of Clinical Trials

勘误：比较西格列汀或磺脲类药物治疗2型糖尿病合并轻度肾功能损害患者的疗效：临床试验的事后分析

期刊:Diabetes Therapy

影响因子:2.6

doi:10.1007/s13300-015-0101-7

Ommen, Elizabeth S; Xu, Lei; O'Neill, Edward A; Goldstein, Barry J; Kaufman, Keith D; Engel, Samuel S

发表日期：2015

文献求助收藏

Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysis

西格列汀治疗2型糖尿病患者的心血管安全性：一项汇总分析

期刊:Cardiovascular Diabetology

影响因子:10.6

doi:10.1186/1475-2840-12-3

Engel, Samuel S; Golm, Gregory T; Shapiro, Deborah; Davies, Michael J; Kaufman, Keith D; Goldstein, Barry J

发表日期：2013

文献求助收藏

Safety and tolerability of sitagliptin in type 2 diabetes: pooled analysis of 25 clinical studies

西格列汀治疗2型糖尿病的安全性和耐受性：25项临床研究的汇总分析

期刊:Diabetes Therapy

影响因子:2.6

doi:10.1007/s13300-013-0024-0

Engel, Samuel S; Round, Elizabeth; Golm, Gregory T; Kaufman, Keith D; Goldstein, Barry J

发表日期：2013

文献求助收藏

Erratum to: Safety and Tolerability of Sitagliptin in Type 2 Diabetes: Pooled Analysis of 25 Clinical Studies

勘误：西格列汀治疗 2 型糖尿病的安全性和耐受性：25 项临床研究的汇总分析

期刊:Diabetes Therapy

影响因子:2.6

doi:10.1007/s13300-013-0031-1

Engel, Samuel S; Round, Elizabeth; Golm, Gregory T; Kaufman, Keith D; Goldstein, Barry J

发表日期：2013

文献求助收藏

Effects of MK-0941, a novel glucokinase activator, on glycemic control in insulin-treated patients with type 2 diabetes

新型葡萄糖激酶激活剂MK-0941对接受胰岛素治疗的2型糖尿病患者血糖控制的影响

doi:10.2337/dc11-1200

Meininger, Gary E; Scott, Russell; Alba, Maria; Shentu, Yue; Luo, Edmund; Amin, Himal; Davies, Michael J; Kaufman, Keith D; Goldstein, Barry J

免疫/内分泌

发表日期：2011

文献求助收藏

Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes

西格列汀在临床研究中的安全性和耐受性：一项纳入10246例2型糖尿病患者数据的汇总分析

期刊:BMC Endocrine Disorders

影响因子:3.3

doi:10.1186/1472-6823-10-7

Williams-Herman, Debora; Engel, Samuel S; Round, Elizabeth; Johnson, Jeremy; Golm, Gregory T; Guo, Hua; Musser, Bret J; Davies, Michael J; Kaufman, Keith D; Goldstein, Barry J

发表日期：2010

文献求助收藏

The association of ENPP1 K121Q with diabetes incidence is abolished by lifestyle modification in the diabetes prevention program

在糖尿病预防计划中，生活方式干预可消除ENPP1 K121Q与糖尿病发病率之间的关联。

期刊:Journal of Clinical Endocrinology & Metabolism

影响因子:5.1

doi:10.1210/jc.2008-1583

Moore, Allan F; Jablonski, Kathleen A; Mason, Clinton C; McAteer, Jarred B; Arakaki, Richard F; Goldstein, Barry J; Kahn, Steven E; Kitabchi, Abbas E; Hanson, Robert L; Knowler, William C; Florez, Jose C

发表日期：2009

文献求助收藏

Role of protein tyrosine phosphatase 1B in vascular endothelial growth factor signaling and cell-cell adhesions in endothelial cells

蛋白酪氨酸磷酸酶1B在血管内皮生长因子信号传导和内皮细胞间黏附中的作用

期刊:Circulation Research

影响因子:16.2

doi:10.1161/CIRCRESAHA.107.167080

Nakamura, Yoshimasa; Patrushev, Nikolay; Inomata, Hyoe; Mehta, Dolly; Urao, Norifumi; Kim, Ha Won; Razvi, Masooma; Kini, Vidisha; Mahadev, Kalyankar; Goldstein, Barry J; McKinney, Ronald; Fukai, Tohru; Ushio-Fukai, Masuko

细胞生物学

发表日期：2008

文献求助收藏